Cargando…
Tspan9 Induces EMT and Promotes Osteosarcoma Metastasis via Activating FAK-Ras-ERK1/2 Pathway
OBJECT: At present, there are few effective treatment options available to patients suffering from osteosarcoma (OS). Clarifying the signaling pathways that govern OS oncogenesis may highlight novel approaches to treating this deadly form of cancer. Recent experimental evidence suggests that the tra...
Autores principales: | Shao, Shijie, Piao, Lianhua, Wang, Jiangsong, Guo, Liwei, Wang, Jiawen, Wang, Luhui, Tong, Lei, Yuan, Xiaofeng, Han, Xu, Fang, Sheng, Zhu, Junke, Wang, Yimin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906905/ https://www.ncbi.nlm.nih.gov/pubmed/35280793 http://dx.doi.org/10.3389/fonc.2022.774988 |
Ejemplares similares
-
Tetraspanin 7 promotes osteosarcoma cell invasion and metastasis by inducing EMT and activating the FAK-Src-Ras-ERK1/2 signaling pathway
por: Shao, Shijie, et al.
Publicado: (2022) -
Erythrocyte membrane protein band 4.1-like 3 inhibits osteosarcoma cell invasion through regulation of Snai1-induced epithelial-to-mesenchymal transition
por: Yuan, Xiaofeng, et al.
Publicado: (2020) -
Knockdown of NSD2 Suppresses Renal Cell Carcinoma Metastasis by Inhibiting Epithelial-Mesenchymal Transition
por: Han, Xu, et al.
Publicado: (2019) -
Cellular functions and molecular mechanisms of ubiquitination in osteosarcoma
por: Song, Jiaxun, et al.
Publicado: (2022) -
TSPAN6 is a suppressor of Ras-driven cancer
por: Humbert, Patrick O., et al.
Publicado: (2022)